Recombinant human LH supplementation versus supplementation with urinary hCG-based LH activity during controlled ovarian stimulation in the long GnRH-agonist protocol: a matched case–control study

Author： Bühler Klaus F.   Fischer Robert  

Publisher： Informa Healthcare

ISSN： 1473-0766

Source： Gynecological Endocrinology, Vol.28, Iss.5, 2012-05, pp. : 345-350

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Recombinant human LH supplementation during GnRH antagonist administration in IVF/ICSI cycles: a prospective randomized study

By Cédrin-Durnerin I.  

Human Reproduction, Vol. 19, Iss. 9, 2004-09 ,pp. : 1979-1984

Oxford University Press

Access to resources Recommend Favorite

Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized controlled trial

By De Placido G.  

Human Reproduction, Vol. 20, Iss. 2, 2005-02 ,pp. : 390-396

Oxford University Press

Access to resources Recommend Favorite

Live-birth rates after HP-hMG stimulation in the long GnRH agonist protocol: association with mid-follicular hCG and progesterone concentrations, but not with LH concentrations

By Arce Joan-Carles   Smitz Johan  

Gynecological Endocrinology, Vol. 29, Iss. 1, 2013-01 ,pp. : 46-50

Informa Healthcare

Access to resources Recommend Favorite

Recombinant LH supplementation to recombinant FSH during the final days of controlled ovarian stimulation for in vitro fertilization. A multicentre, prospective, randomized, controlled trial

By NyboeAndersen A.   Humaidan P.   Fried G.   Hausken J.   Antila L.   Bangsbll S.   Rasmussen P.E.   Lindenberg S.   Bredkjaer H. Ejdrup   Meinertz H.  

Human Reproduction, Vol. 23, Iss. 2, 2008-02 ,pp. : 427-434

Oxford University Press

Access to resources Recommend Favorite

Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation

By European Middle East Orgalutran® Study Group* The  

Human Reproduction, Vol. 16, Iss. 4, 2001-04 ,pp. : 644-651

Oxford University Press

Access to resources Recommend Favorite